79-year-old Dale Cousins improves from prostate cancer with targeted radiation treatment RLT, not yet accessible to non-trial patients.
79-year-old Dale Cousins saw significant improvement in his prostate cancer after receiving a new targeted radiation treatment, but patients not in clinical trials cannot access it yet. Doctors are excited about the treatment's potential, as it delivers lethal radiation specifically to cancer cells, while sparing healthy tissues. The treatment, known as RLT, is expected to become a new "pillar" of cancer care alongside surgery, chemotherapy, and radiation.
July 06, 2024
4 Articles